Cardiovascular Systems, Inc.
CSII · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $61,453 | $59,673 | $62,496 | $56,221 |
| % Growth | 3% | -4.5% | 11.2% | – |
| Cost of Goods Sold | $18,461 | $16,698 | $16,269 | $14,790 |
| Gross Profit | $42,992 | $42,975 | $46,227 | $41,431 |
| % Margin | 70% | 72% | 74% | 73.7% |
| R&D Expenses | $9,533 | $9,056 | $8,773 | $9,052 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $41,642 | $44,475 | $46,593 | $41,680 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $345 | $346 | $346 | $346 |
| Operating Expenses | $51,520 | $53,877 | $55,712 | $51,078 |
| Operating Income | -$8,528 | -$10,902 | -$9,485 | -$9,647 |
| % Margin | -13.9% | -18.3% | -15.2% | -17.2% |
| Other Income/Exp. Net | $689 | $252 | -$157 | $52 |
| Pre-Tax Income | -$7,839 | -$10,650 | -$9,642 | -$9,595 |
| Tax Expense | $49 | -$19 | $48 | $63 |
| Net Income | -$7,888 | -$10,631 | -$9,690 | -$9,658 |
| % Margin | -12.8% | -17.8% | -15.5% | -17.2% |
| EPS | -0.2 | -0.27 | -0.25 | -0.25 |
| % Growth | 25.9% | -8% | 0% | – |
| EPS Diluted | -0.2 | -0.27 | -0.25 | -0.25 |
| Weighted Avg Shares Out | 39,664 | 39,607 | 39,347 | 39,288 |
| Weighted Avg Shares Out Dil | 39,664 | 39,607 | 39,347 | 39,288 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,093 | $658 | $250 | $460 |
| Interest Expense | $404 | $406 | $407 | $408 |
| Depreciation & Amortization | $345 | $1,878 | $346 | $346 |
| EBITDA | -$7,090 | -$9,024 | -$8,889 | -$8,841 |
| % Margin | -11.5% | -15.1% | -14.2% | -15.7% |